72.11.Z - Research and experimental development on biotechnology
70.10.Z - Activities of head office and holding companies, excluding financial holding companies
71.12.Z - Engineering activities and related technical consultancy
71.20.A - Food quality testing and analysis
71.20.B - Other technical testing and analysis
72.19.Z - Other research and experimental development on natural sciences and engineering
72.20.Z - Research and experimental development on social sciences and humanities
74.10.Z - Specialised design activities
74.90.Z - Other professional, scientific and technical activities not elsewhere classified
85.59.B - Other out-of-school forms of education, not elsewhere classified
2019 | 2020 | 2021 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Profit (loss) on sale | 0,2 | 0 | 0,1 | 207,5 |
Gross profit (loss) | 0,2 | 0,1 | -0,2 | -334,8 |
EBITDA | 0,2 | 0,1 | -0,2 | -466 |
Short time liabilities | 0 | 0,2 | 0,2 | 1,3 |
Other operating costs | 0,9 | 1,2 | 2,8 | 133,9 |
Equity capital | 0,1 | 0,2 | -0 | -119,3 |
Operating profit (EBIT) | 0,2 | 0,1 | -0,2 | -466 |
Assets | 1,5 | 1,2 | 2,3 | 93,4 |
Net profit (loss) | 0,2 | 0,1 | -0,2 | -334,8 |
Cash | 0,9 | 0,1 | 0,7 | 472,4 |
Net income from sale | 0,3 | 0,2 | 0,3 | 39,2 |
Liabilities and provisions for liabilities | 1,3 | 1 | 2,3 | 140,3 |
Working assets | 1 | 0,9 | 1,5 | 78,2 |
Other income costs | 0,9 | 1,2 | 2,4 | 99,9 |
Depreciation | 0 | 0 | 0 | 0 |
% | % | % | p.p. | |
Profitability of capital | 111,4 | 45,8 | 558 | 512,2 |
Equity capital to total assets | 9,2 | 18,1 | -1,8 | -19,9 |
Gross profit margin | 45,9 | 46,3 | -78,2 | -124,5 |
EBITDA Margin | 47,2 | 30,5 | -80,3 | -110,8 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 25 | 302 | 220 | -82 |
Current financial liquidity indicator | 44.99076461791992 | 4.936010837554932 | 8.682713508605957 | 3,8 |
Net dept to EBITDA | -5.504753589630127 | -1.9529666900634766 | 3.027894973754883 | 5 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane